Name: Name:tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate
Brand: AABLOCKS
SKU: AA00I5G6
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA00I5G6

Chemical Name: tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate

CAS Number: 298681-10-4

Molecular Formula: C9H17NO4

Molecular Weight: 203.2356

MDL Number: MFCD14635712

SMILES: OC1CN(CC1O)C(=O)OC(C)(C)C

Properties

Complexity: 213

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 14

Hydrogen Bond Acceptor Count: 4

Hydrogen Bond Donor Count: 2

Isotope Atom Count: 0

Rotatable Bond Count: 2

Undefined Atom Stereocenter Count: 2

Undefined Bond Stereocenter Count: 0

XLogP3: -0.4

Downstream Synthesis Route

298681-10-4

473541-96-7

[1]CurrentPatentAssignee:ACADIAPHARMACEUTICALSINC-WO2005/115361,2005,A2Locationinpatent:Page/Pagecolumn68-69

298681-10-4

124-63-0

298681-11-5

[1]CurrentPatentAssignee:SANOFI-US6750348,2004,B1Locationinpatent:Pagecolumn118

73286-70-1

298681-10-4

[1]CurrentPatentAssignee:PERRIGOCOMPANYPUBLICLIMITEDCOMPANY-WO2007/22502,2007,A2Locationinpatent:Page/Pagecolumn86

[2]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[3]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[4]CurrentPatentAssignee:SANOFI-US6750348,2004,B1Locationinpatent:Pagecolumn117-118

[5]CurrentPatentAssignee:ASTRAZENECAPLC-WO2003/82831,2003,A1Locationinpatent:Page/Pagecolumn149

[6]Locationinpatent:schemeortableBowers,Simeon;Probst,GaryD.;Truong,AnhP.;Hom,RoyK.;Konradi,AndreiW.;Sham,HingL.;Garofalo,AlbertW.;Wong,Karina;Goldbach,Erich;Quinn,KevinP.;Sauer,John-Michael;Wallace,William;Nguyen,Lan;Hemphill,SusannaS.;Bova,MichaelP.;Basi,GuriqbalS.[BioorganicandMedicinalChemistryLetters,2009,vol.19,#24,p.6952-6956]

[7]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2021/115065,2021,A1Locationinpatent:Paragraph0681;0714-0715

298681-10-4

103898-12-0

[1]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[2]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[3]Locationinpatent:schemeortableBowers,Simeon;Probst,GaryD.;Truong,AnhP.;Hom,RoyK.;Konradi,AndreiW.;Sham,HingL.;Garofalo,AlbertW.;Wong,Karina;Goldbach,Erich;Quinn,KevinP.;Sauer,John-Michael;Wallace,William;Nguyen,Lan;Hemphill,SusannaS.;Bova,MichaelP.;Basi,GuriqbalS.[BioorganicandMedicinalChemistryLetters,2009,vol.19,#24,p.6952-6956]

[4]CurrentPatentAssignee:PERRIGOCOMPANYPUBLICLIMITEDCOMPANY-WO2007/22502,2007,A2Locationinpatent:Page/Pagecolumn86

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2021/115065,2021,A1Locationinpatent:Paragraph0681;0716

298681-10-4

74-95-3

612501-78-7

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2003/82831,2003,A1Locationinpatent:Page/Pagecolumn149

298681-10-4 | tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate